Acorah Software Products - Accounts Production 16.3.350 false true 31 August 2023 1 September 2022 false true No description of principal activity 1 September 2023 31 August 2024 31 August 2024 13554080 Dr Sugato CHAKRABORTY iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13554080 2023-08-31 13554080 2024-08-31 13554080 2023-09-01 2024-08-31 13554080 frs-core:CurrentFinancialInstruments 2024-08-31 13554080 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 13554080 frs-bus:FilletedAccounts 2023-09-01 2024-08-31 13554080 frs-bus:Micro-entities 2023-09-01 2024-08-31 13554080 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 13554080 frs-bus:Director1 2023-09-01 2024-08-31 13554080 2022-08-31 13554080 2023-08-31 13554080 2022-09-01 2023-08-31 13554080 frs-core:CurrentFinancialInstruments 2023-08-31
Registered number: 13554080
RXNANO LTD
Unaudited Financial Statements
For The Year Ended 31 August 2024
Balance Sheet
Registered number: 13554080
2024 2023
£ £
Current assets 135,482 152,506
Creditors: Amounts Falling Due Within One Year (40,753 ) (41,879 )
NET CURRENT ASSETS 94,729 110,627
TOTAL ASSETS LESS CURRENT LIABILITIES 94,729 110,627
NET ASSETS 94,729 110,627
CAPITAL AND RESERVES 94,729 110,627

Notes

1. General Information
RXNANO LTD is a private company, limited by shares, incorporated in England & Wales, registered number 13554080 . The registered office is 52 Coppice Green, , Westbrook, , Warrington,, WA5 7WA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Sugato CHAKRABORTY
Director
25/05/2025